Pages that link to "Item:Q3186128"

The following pages link to MODELING THE DRUG THERAPY FOR HIV INFECTION (Q3186128):

Displaying 48 items.

• Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects (Q253629) (← links)
• A general framework for multi-compartmental analysis of drug chemotherapy dynamics in human immunodeficiency virus type-1 infected individuals (Q345447) (← links)
• A fractional-order model of HIV infection with drug therapy effect (Q467103) (← links)
• A model incorporating combined RTIs and PIs therapy during early HIV-1 infection (Q512691) (← links)
• Modelling two different therapy strategies for drug T-20 on HIV-1 patients (Q536537) (← links)
• Continuous and discrete modeling of HIV-1 decline on therapy (Q782864) (← links)
• Chronic hepatitis B infection and HBV DNA-containing capsids: modeling and analysis (Q907619) (← links)
• A nonlinear three-compartment model for the administration of 2',3'- dideoxycytidine by using red blood cells as bioreactors (Q920050) (← links)
• Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: the role of fusion inhibitors in HAART (Q1006244) (← links)
• Dynamics of the HIV infection under antiretroviral therapy: a cellular automata approach (Q1673233) (← links)
• Modeling of fusion inhibitor treatment of RSV in African green monkeys (Q1714364) (← links)
• Modelling the drugs therapy for HIV infection with discrete-time delay (Q1723784) (← links)
• Modelling optimal control of in-host HIV dynamics using different control strategies (Q1734437) (← links)
• Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy (Q1788644) (← links)
• Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor (Q1788684) (← links)
• Modeling defective interfering virus therapy for AIDS: Conditions for DIV survival (Q1804865) (← links)
• Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics (Q1961939) (← links)
• Modeling the role of acquired immune response and antiretroviral therapy in the dynamics of HIV infection (Q1996972) (← links)
• Analysis of a fractional model for HIV CD\(4^+\) T-cells with treatment under generalized Caputo fractional derivative (Q2130784) (← links)
• Global dynamics of an age-structured model for HIV viral dynamics with latently infected T cells (Q2140052) (← links)
• Bessel-quasilinearization technique to solve the fractional-order HIV-1 infection of CD\(4^+\) T-cells considering the impact of antiviral drug treatment (Q2152718) (← links)
• Optimal control of an HIV infection model with logistic growth, celluar and homural immune response, cure rate and cell-to-cell spread (Q2153840) (← links)
• Effects of periodic intake of drugs of abuse (morphine) on HIV dynamics: mathematical model and analysis (Q2197760) (← links)
• Emergence of drug-resistance in HIV dynamics under distinct HAART regimes (Q2198567) (← links)
• Modeling the intracellular pathogen-immune interaction with cure rate (Q2198949) (← links)
• An in-host HIV-1 infection model incorporating quiescent and activated \(\mathrm{CD}4^+\) T cells as well as CTL response (Q2244179) (← links)
• Modeling interactions between \(\mathrm{C}_{60}\) antiviral compounds and HIV protease (Q2352442) (← links)
• Geometric stability switch criteria in HIV-1 infection delay model (Q2633554) (← links)
• Investigation of fractal-fractional HIV infection by evaluating the drug therapy effect in the Atangana-Baleanu sense (Q2693576) (← links)
• Dynamical model of in-host HIV infection: with drug therapy and multi viral strains (Q2871162) (← links)
• A fractional-order model of HIV infection: numerical solution and comparisons with data of patients (Q2922120) (← links)
• Analysis of a sex-structured HIV/AIDS model with the effect of screening of infectives (Q2933554) (← links)
• THE DYNAMICS OF HIV MODELS WITH SWITCHING PARAMETERS AND PULSE CONTROL (Q2977788) (← links)
• Effects of combined drug therapy on HIV-1 infection dynamics (Q3188729) (← links)
• A delayed HIV infection model with apoptosis and viral loss (Q3300972) (← links)
• STABILITY ANALYSIS AND OPTIMAL CONTROL OF AN INTRACELLULAR HIV INFECTION MODEL WITH ANTIRETROVIRAL TREATMENT (Q5003139) (← links)
• Modeling the dynamics of viral–host interaction during treatment of productively infected cells and free virus involving total immune response (Q5009871) (← links)
• Analysis of time delay model for drug therapy on HIV dynamics (Q5025474) (← links)
• Stability analysis and numerical simulations of spatiotemporal HIV CD4+ T cell model with drug therapy (Q5129875) (← links)
• MODELING THE SPREAD OF HIV IN A STAGE STRUCTURED POPULATION: EFFECT OF AWARENESS (Q5166821) (← links)
• EFFECTS OF ECLIPSE PHASE AND DELAY ON THE DYNAMICS OF HIV INFECTION (Q5230389) (← links)
• Time-adaptive FEM for distributed parameter identification in mathematical model of HIV infection with drug therapy (Q5253425) (← links)
• INFLUENCE OF DRUG PHARMACOKINETICS ON HIV PATHOGENESIS AND THERAPY (Q5326049) (← links)
• Viral Dynamic Model of Antiretroviral Therapy Including the Integrase Inhibitor Raltegravir in Patients with HIV-1 (Q5738257) (← links)
• Comparative Study of Some Numerical Schemes for a Fractional Order Model of HIV Infection Treatment (Q6088864) (← links)
• Bifurcation analysis of HIV infection model with cell-to-cell transmission and non-cytolytic cure (Q6118927) (← links)
• Time-adaptive determination of drug efficacy in mathematical model of HIV infection (Q6144616) (← links)
• Stability and optimal control of age‐structured cell‐free and cell‐to‐cell transmission model of HIV (Q6193102) (← links)